In cancer, downregulation of E-cadherin has been shown to play a crucial role in the progression of well differentiated adenoma to invasive carcinoma [20], and E-cadherin is therefore considered to act as a tumor suppressor [21]. This evidence concerns the gene CDH1 and neoplasm.